Belimumab combined with standard therapy does not increase adverse effects compared with a control treatment: A systematic review and meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Belimumab combined with standard therapy does not increase adverse effects compared with a control treatment: A systematic review and meta-analysis of randomised controlled trials

Published:2022-08 Issue: Volume:109 Page:108811
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Xu Ying^ORCID,Xu Jia-wen,Wang Yan-jiao,Tung Tao-Hsin,Chien Ching-Wen^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. The global burden of SLE: prevalence, health disparities and socioeconomic impact;Carter;Nat. Rev. Rheumatol.,2016

2. Systemic lupus erythematosus;Lisnevskaia;Lancet,2014

3. Mortality in systemic lupus erythematosus;Bernatsky;Arthritis Rheum.,2006

4. Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management;Fortuna;Dent. Clin. North Am.,2013

5. Management strategies and future directions for systemic lupus erythematosus in adults;Durcan;Lancet,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study;Lupus;2024-03-22

2. Mental disorders in children with rheumatic diseases;Rheumatology Science and Practice;2024-03-01

3. Patients with cardiovascular disorders and suicidality: A systematic review and meta-analysis;Asian Journal of Psychiatry;2023-12

4. Belimumab‐induced papular elastorrhexis: A case report;Australasian Journal of Dermatology;2023-10-15

5. The effect and safety of Bushen Huoxue Method combined with cyclophosphamide in the treatment of systemic lupus erythematosus: A protocol for systematic review and meta-analysis;Medicine;2022-11-25